Drug Profile
Desonide foam
Alternative Names: Desilux; Verdeso FoamLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Stiefel Laboratories
- Class Anti-inflammatories; Glucocorticoids; Pregnadienetriols; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Atopic dermatitis
Most Recent Events
- 16 Jan 2014 Aqua Pharmaceuticals has been acquired by Almirall S.A.
- 22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
- 28 Dec 2006 Connetics Corporation has been acquired and merged into Stiefel Laboratories